Stockholm Centre for Eating Disorders, Stockholm, Sweden.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Stockholm County Council, Sweden.
Int J Eat Disord. 2019 Apr;52(4):331-360. doi: 10.1002/eat.22962. Epub 2018 Nov 29.
Avoidant/restrictive food intake disorder (ARFID) was introduced as a new diagnosis in the DSM-5. This systematic scoping review explores how ARFID as a diagnostic entity is conceptualized in the research literature and evaluates the diagnostic validity according to the Feighner criteria.
A systematic scoping review of papers on ARFID in PubMed/MEDLINE and Web of Science was undertaken, following PRISMA and Joanna Briggs Institute guidelines.
Fifty-one original research publications, 23 reviews and commentaries, and 20 case reports were identified. The use of ARFID as a conceptual category varies significantly within this literature. At this time, the ARFID diagnosis does not fulfil the Feighner criteria for evaluating the validity of diagnostic constructs, the most urgent problem being the demarcation toward other disorders. A three-dimensional model-lack of interest in food, selectivity based on sensory sensitivity, and fear of aversive consequences-is gaining support in the research literature.
The introduction of the ARFID diagnosis has undoubtedly increased the recognition of a previously largely neglected group of patients. However, this article points to an inability of the current DSM-5 diagnostic criteria to ensure optimal diagnostic validity, which risks making them less useful in clinical practice and in epidemiological research. To increase the conceptual validity of the ARFID construct, several possible alterations to the current diagnostic criteria are suggested, including a stronger emphasis of the three identified subdomains and further clarifying the boundaries of ARFID.
回避/限制型食物摄入障碍(ARFID)作为一种新的诊断被纳入 DSM-5。本系统范围综述探讨了 ARFID 作为一种诊断实体在研究文献中是如何被概念化的,并根据 Feighner 标准评估其诊断有效性。
按照 PRISMA 和 Joanna Briggs 研究所的指南,对 PubMed/MEDLINE 和 Web of Science 上关于 ARFID 的论文进行了系统的范围综述。
共确定了 51 篇原始研究出版物、23 篇综述和评论以及 20 篇病例报告。在这一文献中,ARFID 作为一个概念类别被广泛使用。目前,ARFID 诊断不符合评估诊断结构有效性的 Feighner 标准,最紧迫的问题是与其他疾病的划分。缺乏对食物的兴趣、基于感官敏感性的选择性以及对不良后果的恐惧的三维模型在研究文献中得到了支持。
回避/限制型食物摄入障碍诊断的引入无疑提高了对以前被广泛忽视的患者群体的认识。然而,本文指出当前 DSM-5 诊断标准无法确保最佳诊断有效性,这有可能使其在临床实践和流行病学研究中变得不那么有用。为了提高 ARFID 结构的概念有效性,提出了对当前诊断标准的几个可能的修改,包括更加强调三个已确定的亚领域,并进一步澄清 ARFID 的边界。